BERKELEY, Calif.--(BUSINESS WIRE)--Somnee – the first personalized, smart sleep headband that utilizes non-invasive, closed-loop neurostimulation for longer, higher quality sleep – today announced the appointment of Tim Rosa as its Chief Executive Officer (CEO). Leveraging expertise across the health and wellness industry and an unprecedented track record in scaling companies, Rosa will guide the company through its next phase of growth as it continues in its mission to help people sleep better through personalized neuroscience.

加州伯克利讯（商业新闻短讯）--Somnee是第一款个性化智能睡眠头带，它利用非侵入性闭环神经刺激来获得更长、更高质量的睡眠，今天宣布任命蒂姆·罗莎为首席执行官（CEO）。Rosa将利用整个健康和保健行业的专业知识以及规模化公司前所未有的业绩记录，指导公司完成下一阶段的增长，同时继续通过个性化神经科学帮助人们睡得更好。

Somnee is the sleep product line developed by StimScience..

Somnee是StimScience开发的睡眠产品系列。。

“There’s a lot of exciting clinical research and momentum validating the importance of sleep fitness and its impact on cognitive performance, athletic performance, mental health, general health, and even weight loss,” said Rosa. “Wearables have done a great job educating consumers on their general sleep stage trends and insights.

罗莎说：“有许多令人兴奋的临床研究和势头证实了睡眠健康的重要性及其对认知能力、运动能力、心理健康、总体健康甚至减肥的影响。”。“可穿戴设备在教育消费者睡眠阶段的总体趋势和见解方面做得很好。

The challenge for most consumer-grade devices has been creating a closed-loop, lab-grade diagnostic in combination with a personalized therapeutic that adapts with the user and ultimately improves sleep onset, duration, and/or depth. I’m excited to partner with wearables, sleep products and services, and healthcare to close that loop and improve outcomes for 100 million consumers.

大多数消费者级设备面临的挑战是创建闭环实验室级诊断，并结合个性化治疗方法，以适应用户并最终改善睡眠发作，持续时间和/或深度。我很高兴能与可穿戴设备、睡眠产品和服务以及医疗保健合作，以结束这一循环，并为一亿消费者改善结果。

With StimScience, the team has pioneered and delivered lab-grade technology in a sleep headband that accurately maps and measures brainwave patterns and applies personalized tES neurostimulation that nudges the brain to sleep.”.

凭借StimScience，该团队在睡眠头带中开创并提供了实验室级技术，该技术可以准确地映射和测量脑波模式，并应用个性化的tES神经刺激，推动大脑入睡。”。

Rosa was recruited as CEO in November 2023 by renowned sleep expert and Somnee’s Chief Sleep Advisor Dr. Matthew Walker, PhD, and pioneering technology investor Vinod Khosla of Khosla Ventures. As the consumer sleep market continues to see record growth, Rosa’s immediate focus will be raising the company’s next round of funding, building brand awareness, spearheading the near-term launch of multiple new products and service enhancements, and further solidifying Somnee’s position as a pioneering leader in sleep fitness and other neurological health disorders..

2023年11月，著名睡眠专家、Somnee首席睡眠顾问Matthew Walker博士和科斯拉风险投资公司的开拓性技术投资者Vinod Khosla聘请Rosa担任首席执行官。随着消费者睡眠市场的持续创纪录增长，罗莎的当务之急将是提高公司的下一轮资金，建立品牌知名度，率先推出多项新产品和服务改进，并进一步巩固索姆尼在睡眠健康和其他神经健康疾病领域的领先地位。。

“Technology is a catalyst for the positive innovation necessary to tackle the largest human challenges. We backed Somnee because the team had every component needed to bring forward clinical-grade consumer technology to change the face of sleep. Since our initial investment, this thesis is proving itself out,” said Vinod Khosla, founder of Khosla Ventures.

科斯拉风险投资公司（Khosla Ventures）创始人维诺德·科斯拉（Vinod Khosla）表示：“技术是应对人类最大挑战所必需的积极创新的催化剂。我们支持索姆尼，因为该团队拥有提出临床级消费技术以改变睡眠面貌所需的每一个组成部分。自我们最初投资以来，这一论点得到了证明。”。

“With Tim at the helm, Somnee can now scale to bridge a foundational health gap and cement itself as an iconic brand that carries weight with consumers, the medical and sleep health communities.”.

“有了蒂姆的领导，索姆尼现在可以扩大规模，弥合基本的健康差距，巩固自己作为一个标志性品牌的地位，在消费者、医疗和睡眠健康社区中占有一席之地。”。

Rosa brings over 20 years of experience in consumer and enterprise marketing, business management, and launching world-class brands, products, and services. As the former Chief Marketing Officer (CMO) at Fitbit, he was pivotal in establishing the connected health and fitness wearables category. Rosa scaled the company from a startup into a top 20 consumer brand, selling over 140 million devices in 100+ countries and helping to drive the largest consumer electronics IPO in history.

Rosa在消费者和企业营销、商业管理以及推出世界级品牌、产品和服务方面拥有20多年的经验。作为Fitbit的前首席营销官（CMO），他在建立互联健康和健身可穿戴设备类别方面发挥了关键作用。Rosa将该公司从一家初创公司发展为前20大消费品牌，在100多个国家销售了超过1.4亿台设备，并帮助推动了历史上最大规模的消费电子产品IPO。

Rosa wrapped his seven year tenure with Fitbit’s $2.1B sale to Google. Adapting this successful playbook, he will leverage his expertise to carve the same category-defining growth path for Somnee..

罗莎（Rosa）以菲比特（Fitbit）以21亿美元的价格将其7年任期出售给谷歌（Google）。通过改编这本成功的剧本，他将利用自己的专业知识为Somnee开辟同一类别的增长道路。。

In the next 24 months, Rosa will build a world-class executive leadership team, evolve the company’s product line, expand strategic partnerships, open new retail, employer, and payer channels, complete a healthcare pilot study, and elevate broader conversations around sleep fitness.

在接下来的24个月里，罗莎将建立一支世界一流的高管领导团队，发展公司的产品线，扩大战略合作伙伴关系，开辟新的零售、雇主和付款人渠道，完成一项医疗保健试点研究，并提升围绕睡眠健康的更广泛对话。

“Sleep is increasingly recognized as one of the most fundamental habits not only for our day-to-day functioning, concentration, mood, and body health, but also for continued brain and body wellness as we age,” said Dr. Matthew Walker, Ph.D., Chief Sleep Advisor at Somnee. “Quality and duration of sleep impact hormone levels, obesity and diabetes, cancer immune factors, and are associated with Alzheimer’s disease.

Somnee首席睡眠顾问Matthew Walker博士说：“睡眠越来越被认为是最基本的习惯之一，不仅对我们的日常功能、注意力、情绪和身体健康至关重要，而且随着年龄的增长，它也对大脑和身体的持续健康至关重要。”。睡眠质量和持续时间会影响激素水平、肥胖和糖尿病、癌症免疫因素，并与阿尔茨海默病有关。

With sleep deprivation officially recognized as a public health issue, it’s crucial to continue spreading accessible education and resources, but also, new brain stimulation methods to help people prioritize and achieve a good night’s rest.”.

随着睡眠不足被正式视为公共卫生问题，至关重要的是继续传播可获得的教育和资源，以及新的大脑刺激方法，以帮助人们优先考虑并实现良好的夜间休息。”。

Despite the critical role sleep plays in proactively maintaining health and preventing chronic disease, more than a third of U.S. adults do not regularly get enough uninterrupted sleep. Somnee is the first device of its kind that uses a revolutionary approach to sleep improvement through personalized closed-loop neurostimulation – integrating sleep lab-grade technology into a wearable headband.

尽管睡眠在积极维护健康和预防慢性病方面起着至关重要的作用，但超过三分之一的美国成年人没有定期获得足够的不间断睡眠。Somnee是同类设备中第一款采用革命性方法通过个性化闭环神经刺激改善睡眠的设备，该方法将睡眠实验室级技术集成到可穿戴头带中。

It's the only device proven to cut the time it takes to fall asleep in half and dramatically improve sleep quality with just 15 minutes of use. Somnee is 4x the effectiveness of a melatonin pill, 2x more effective than Cognitive Behavior Therapy (CBT-i), and 1.5x more effective than Ambien in improving sleep efficiency and duration – delivering a novel combination of effectiveness with the ease of use consumers desire..

它是唯一一款被证明可以将入睡时间减半并显著改善睡眠质量的设备，只需使用15分钟。Somnee是褪黑激素药丸的4倍，比认知行为疗法（CBT-i）有效2倍，在提高睡眠效率和持续时间方面比Ambien有效1.5倍-提供了一种新颖的有效性和易用性的组合消费者的愿望。。

About Somnee

关于Somnee

Somnee is on a mission to help everyone sleep better through personalized neuroscience. Built upon decades of research and development, Somnee is the first smart sleep headband to help your brain naturally achieve a longer, higher-quality night’s sleep. The Somnee founding research team includes world-leading neuroscientists Matthew Walker, Ph.D., author of NY Times bestseller Why We Sleep and Director of UC Berkeley’s Center of Human Sleep Science; Robert Knight, M.D., Professor of Psychology and Neuroscience at UC Berkeley; Rich Ivry, Ph.D., Professor of Psychology and Neuroscience at UC Berkeley; and founder, Ram Gurumoorthy, Ph.D., former Chief Science and Technology Officer at Nielsen-acquired NeuroFocus Inc.

Somnee的使命是通过个性化的神经科学帮助每个人睡得更好。经过数十年的研究和开发，Somnee是第一款智能睡眠头带，可帮助大脑自然获得更长、更高质量的夜间睡眠。Somnee创始研究团队包括世界领先的神经科学家Matthew Walker博士、《纽约时报》畅销书《为什么我们睡觉》的作者以及加州大学伯克利分校人类睡眠科学中心的主任；加州大学伯克利分校心理学和神经科学教授罗伯特·奈特（RobertKnight），医学博士；Rich Ivry博士，加州大学伯克利分校心理学和神经科学教授；尼尔森收购NeuroFocus Inc.的创始人、前首席科技官拉姆·古鲁穆尔西（RamGurumoorthy）博士。

Khosla Ventures led Somnee’s seed round to pioneer the next frontier of sleep health and other neurological health disorders. To learn more about Somnee, visit: www.somneesleep.com..

科斯拉风险投资公司（Khosla Ventures）带领索姆尼（Somnee）的种子轮开创了睡眠健康和其他神经健康疾病的下一个前沿领域。要了解更多关于Somnee的信息，请访问：www.somneesleep.com。。